Atara Biotherapeutics (ATRA) vs LENZ Therapeutics (LENZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Atara Biotherapeutics (ATRA) has outperformed LENZ Therapeutics (LENZ) over the past year, losing 40.1% versus a loss of 92.3%. Over five years, LENZ leads with a -96.0% price change compared with -97.5% for ATRA. LENZ Therapeutics is the larger company by market cap ($113.7 million vs $94.1 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATRA | LENZ |
|---|---|---|
| Share price | $9.37 | $3.62 |
| Market cap | $94.05M | $113.74M |
| 1-day change | -3.90% | -4.49% |
| YTD return | -48.20% | -77.38% |
| 1-year return | -40.05% | -92.29% |
| 5-year return | -97.52% | -95.95% |
| Forward P/E | 6.06 | — |
| EPS (TTM) | $-1.30 | $-4.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.15 | $49.25 |
| 52-week low | $3.92 | $3.46 |
| Distance from 52-week high | -51.06% | -92.65% |
| Average volume | 57.16K | 838.15K |
| Shares outstanding | 10.04M | 31.42M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ATRA has outperformed LENZ by 52.2 percentage points over the past year.
ATRA vs LENZ FAQ
Which is bigger, Atara Biotherapeutics or LENZ Therapeutics?
LENZ Therapeutics (LENZ) is larger, with a market capitalization of $113.74M compared with $94.05M for Atara Biotherapeutics (ATRA).
Which stock has performed better over the past year, ATRA or LENZ?
ATRA returned -40.05% over the past 12 months, compared with -92.29% for LENZ (price return, excluding dividends). Past performance does not predict future results.
Are Atara Biotherapeutics and LENZ Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.